Skip to content

Compression Therapy Following Truncal Vein Endothermal Ablation And Distal Sclerotherapy

Compression Therapy Following Truncal Vein Endothermal Ablation And Distal Sclerotherapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02890563
Enrollment
200
Registered
2016-09-07
Start date
2016-08-31
Completion date
2019-03-31
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose Veins

Keywords

Varicose veins, Compression stockings, Sclerotherapy, Radiofrequency ablation

Brief summary

Study purpose is to research whether compression therapy is beneficial after truncal vein RF-ablation and distal sclerotherapy done in the same session when needed. Patients will be randomised to either no compression group (Group I) or compression group (Group II)

Detailed description

In this study two endpoints are anticipated, first endpoint is to assess safety and adverse effects between groups at 1 month endpoint. Also post-procedural pain and need for painkillers are monitored. Compliance and reasons for non-compliance is recorded in compression group. Second endpoint is to assess mid-term (6 months) success of truncal vein occlusion as well as changes in Aberdeen score between groups compared to pre-operative stage. Study design is non-inferiority trial where in 5% margin occlusion of truncal vein is expected to be equal in two groups at 6 six months. Power analysis showed need for 85 patients per group and taking into account possible dropouts anticipated n = 200.

Interventions

Sponsors

Oulu University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Duplex ultrasound verified GSV and/or SSV incompetence (0.5 seconds or more) * Comprehensive Classification System for Chronic Venous Disorders (CEAP) rated from C2 to C4 * Truncal vein insufficiency (GSV and/or SSV) treatable with Radiofrequency ablation

Exclusion criteria

* History of pulmonary embolism or deep venous thrombosis * Large (\>12mm) truncal vein diameter * CEAP C5-C6 * Patient unwilling to participate

Design outcomes

Primary

MeasureTime frame
Truncal vein occlusion rate6 months

Secondary

MeasureTime frameDescription
Painkillers usage after treatment10 daysNeed for Paracetamol/NSAIDs after treatment
Aberdeen Varicose Veins Questionnaire (AVVQ)6 monthsAssessed preoperatively and at one and six months
Post-operative pain assessed with visual analogue scale (VAS)10 days
Time required returning to normal work and activity level14 days
Signs of deep venous thrombosis, pigmentation, blisters, skin irritation, thrombophlebitis, hematoma, wound infection or paraesthesia post operatively30daysAssessed in 1month control and earlier if necessary (Patient is instructed to contact outpatient clinic in case of problems).
Compliance with compression stockings7 daysTo assess compliance and possible reasons for non-compliance at compression group

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026